Literature DB >> 10456878

Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Y Zhang1, E Y Denkers.   

Abstract

To investigate the role of interleukin-5 (IL-5) during Toxoplasma gondii infection, IL-5 knockout (KO) mice and C57BL/6 control mice were infected intraperitoneally with ME49 cysts and the course of infection was monitored. The mortality rate during chronic infection was significantly greater in IL-5-deficient animals, and consistent with this finding, the KO mice harbored a greater number of brain cysts and tachyzoites than did their wild-type counterparts. Although the IL-5 KO animals did not succumb until late during infection, increased susceptibility, as measured by accelerated weight loss, was detectable during the acute stages of infection. The amounts of total immunoglobulin (Ig), IgM, and IgG2b were comparable in both strains, while the amount of IgG1 was much smaller in IL-5 KO mice. Spleen cell production of IL-12 in response to T. gondii antigen was approximately threefold lower in the KO strain, and this decrease correlated with a selective loss of B lymphocytes during culture. A link between the presence of B cells and augmented IL-12 production was established by the finding that after removal of B cells with monoclonal antibody and complement, wild-type- and KO-derived cells produced equivalent levels of IL-12 in response to T. gondii antigen. These results demonstrate a protective role of IL-5 against T. gondii infection and suggest that IL-5 may play a role in the production of IL-12.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456878      PMCID: PMC96756     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Role of IL12 in induction of cell-mediated immunity to Toxoplasma gondii.

Authors:  T Scharton-Kersten; E Y Denkers; R Gazzinelli; A Sher
Journal:  Res Immunol       Date:  1995 Sep-Oct

2.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Authors:  R T Gazzinelli; M Wysocka; S Hieny; T Scharton-Kersten; A Cheever; R Kühn; W Müller; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

3.  Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.

Authors:  A Sartori; X Ma; G Gri; L Showe; D Benjamin; G Trinchieri
Journal:  Methods       Date:  1997-01       Impact factor: 3.608

4.  IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression.

Authors:  K Ochiai; M Kagami; R Matsumura; H Tomioka
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

Review 5.  The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion.

Authors:  S L Swain; D T McKenzie; R W Dutton; S L Tonkonogy; M English
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

6.  Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5.

Authors:  T Taguchi; W K Aicher; K Fujihashi; M Yamamoto; J R McGhee; J A Bluestone; H Kiyono
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

7.  Helper interleukins are produced by both CD4 and CD8 splenic T cells after mitogen stimulation.

Authors:  S Cardell; B Sander; G Möller
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

8.  Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines.

Authors:  P R Bohjanen; M Okajima; R J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice.

Authors:  S J Parker; C W Roberts; J Alexander
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

10.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Concepts of immunostimulation to increase antiparasitic drug action.

Authors:  K Noel Masihi
Journal:  Parasitol Res       Date:  2003-01-08       Impact factor: 2.289

2.  Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection.

Authors:  M B Nickdel; F Roberts; F Brombacher; J Alexander; C W Roberts
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite.

Authors:  L Le Goff; P Loke; H F Ali; D W Taylor; J E Allen
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Effects of Toxoplasma gondii on Levels of Interleukin-5 in Parkinson's Patients.

Authors:  S Hasan Kadhum Al-Huchaimi; G Hameed Neamah Al-Kefaei; B Ahmed Alameedy
Journal:  Arch Razi Inst       Date:  2022-02-28

5.  Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus brasiliensis infection.

Authors:  Oliver Liesenfeld; Ildiko R Dunay; Klaus J Erb
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

6.  Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.

Authors:  Angelika Wagner; Irma Schabussova; Bärbel Ruttkowski; Roman Peschke; Józef Kur; Michael Kundi; Anja Joachim; Ursula Wiedermann
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs' Uveitis.

Authors:  Dominika Pohlmann; Stephan Schlickeiser; Sylvia Metzner; Matthias Lenglinger; Sibylle Winterhalter; Uwe Pleyer
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

8.  Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis.

Authors:  R García-Muñoz; P Rodríguez-Otero; A Galar; J Merino; J J Beunza; J A Páramo; R Lecumberri
Journal:  Adv Hematol       Date:  2009-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.